Clinical Trials Logo

Clinical Trial Summary

To Analyze the Ability of Optical Coherence Tomography Angiography ( OCT-A ) to detect the presence of myopic Choroidal Neovascularization and to describe the structural features of Myopic CNV..


Clinical Trial Description

To Analyze the Ability of Optical Coherence Tomography Angiography ( OCT-A ) to detect the presence of myopic Choroidal Neovascularization and to describe the structural features of Myopic CNV.. regarding the size , shape , core , margin , Appearance , and activity of CNV.. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06357559
Study type Observational
Source Sohag University
Contact Ahmed Hamdy
Phone 01287307536
Email fcb9976@Gmail.com
Status Not yet recruiting
Phase
Start date April 30, 2024
Completion date December 1, 2024

See also
  Status Clinical Trial Phase
Completed NCT05677685 - VISUPRIME® Eye Drops N/A
Active, not recruiting NCT03797547 - Real Life Study in Myopic Neovascularization
Completed NCT03971162 - Intravitreal Conbercept Injection in Patients With Myopic Choroidal Neovascularization N/A
Recruiting NCT05494775 - Effect of Corona Virus on Intravitreal Injections N/A
Suspended NCT04222842 - CM082 in Patients With Myopic Choroidal Neovascularization (CNV) Phase 1